Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Models of Primary Hyperinsulinemia: Diazoxide Suppression Test (DzST) Pilot & Feasibility Study

NCT06606327 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT06606327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06606327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Models of Primary Hyperinsulinemia: Diazoxide Suppression Test (DzST) Pilot & Feasibility Study
Lead sponsor
Columbia University
Phase
Phase 1
Overall status
Terminated
Start date
October 23, 2024
Completion date
June 10, 2026
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperinsulinemia, insulin resistance, obesity